Autism

Description Paliperidone is a new second generation antipsychotic; in terms of pharmacology, it is an active metabolite of risperidone. Compared to risperidone, paliperidone should thus show more stable occupation of dopamine receptors in the brain, which on one the hand may lead to increased antipsychotic efficacy, and on the other hand to […]

On Friday, Johnson & Johnson said in a filing with the US Securities and Exchange Commission that it had reached a settlement to resolve all of the roughly 9,000 cases that it faced over its anti-psychotic drug Risperdal.   The lawsuits generally accused Johnson & Johnson of failing to warn consumers of the risk of gynecomastia, […]

Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed that it recorded $800 million in expenses in connection with the agreement. J&J said in a filing with the U.S. Securities and Exchange […]

Over the last few months, Johnson & Johnson has made sweeping moves to resolve a mountain of litigation involving the safety and marketing of its opioid and talc products. Friday brought word of a lower-profile resolution, as J&J revealed it has settled liability claims surrounding its antipsychotic drug Risperdal. The $800 million settlement was struck […]

Oct 30 (Reuters) – Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed that it recorded $800 million in expenses in connection with the agreement. J&J said in a filing with the […]

(Reuters) – Johnson & Johnson said it has settled most of the lawsuits it faced by thousands of men who claimed its anti-psychotic drug Risperdal caused them to develop excessive breast tissue and disclosed that it recorded $800 million in expenses in connection with the agreement. J&J said in a filing with the U.S. Securities […]